ARTL - Artelo Biosciences Inc. (ARTL) CEO Gregory Gorgas Presents at Q1 Virtual Investor Summit Conference (Transcript)

Artelo Biosciences, Inc. (ARTL) Q1 Virtual Investor Summit Conference March 23, 2021 01:00 PM ET Company Participants Gregory Gorgas - President & Chief Executive Officer Conference Call Participants Presentation Operator You have joined the meeting as an attendee, and will be muted throughout the meeting. Unidentified Company Representative Greg, please share your screen from your slide deck and take it away. Gregory Gorgas All right, thank you very much. And I just want to confirm, you can see my screen. Unidentified Company Representative Yes, absolutely. Unidentified Company Representative Yes. Gregory Gorgas Okay, great. So thank you very much for being here at the Investor Summit. And I'm pleased to be able to share with you about Artelo Biosciences over the next 20 minutes. We're a clinical stage biopharmaceutical company. We're focused in on targeting novel therapeutics that modulate endogenous signaling or lipid-signaling pathways, most notably the endocannabinoid system. We are

For further details see:

Artelo Biosciences, Inc. (ARTL) CEO Gregory Gorgas Presents at Q1 Virtual Investor Summit Conference (Transcript)